Biomarker analysis reveals several potential treatment targets in subtype of anal cancer

Related posts:

1. Human Hendra drug, treatment not prevention In a world first in the battle against the deadly Hendra virus, volunteers are being recruited to trial a human treatment for the virus....
2. The analogy that builds human thought Only human beings (with rare exceptions) are able to grasp analogies. A study carried out in collaboration with SISSA (and the Northwestern University) has investigated the origin of this ability......
3. ‘Green chemistry’ to quantify the components of cosmetics There are 10,000 components that can be used to make cosmetics. These components have to be monitored to guarantee consumer safety. Scientists have now developed three 'green' analytical methods to simultaneously analyze various components used in cosmetics. In these methods very little solvent is used and very little residue is produced in comparison with other analytical techniques....
4. Microscopic sonic screwdriver invented Engineers have created tiny acoustic vortices and used them to grip and spin microscopic particles suspended in water....
5. Targeted drug can ‘diminish the suffering’ of myelofibrosis Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent....